GSK to buy US biotech firm IDRx for up to $1.15 billion
(Reuters) -British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical ...
Medindia1y
GlaxoSmithKline Defends Its Products
Pharmaceutical company GlaxoSmithKline which produces Panadol products like Panadol Extra has sought to dispel doubts with regard to the safety of its products. Pharmaceutical company ...
pharmaphorum6d
Novartis and GSK’s multi-billion dollar swaps to transform both companies
The four-pronged strategy begins with the acquisition of GSK's oncology portfolio, which includes all of its marketed products and late-stage candidates, for $14.5 billion, with a further $1.5 ...
J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...
CNN4y
GSK plc Sponsored ADR
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...
GSK Enters Agreement to Acquire IDRx, Inc.
GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will ...
Anadolu Ajansi5d
GSK to buy US biopharmaceutical company IDRx for $1.15B
Boston-based biotechnology firm developing therapy for treatment of gastrointestinal stromal tumors - Anadolu Ajansı ...
Bernstein Remains a Buy on GlaxoSmithKline (GSK)
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...
GlobalData on MSN12d
China’s NMPA approves GSK’s Nucala for CRSwNP treatment
The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...